Episode #4: Breaking Barriers in Drug Delivery for Women

Episode #4: Breaking Barriers in Drug Delivery for Women

Author: by FemmeHealth Alliance January 19, 2025 Duration: 31:14

In this episode of FemmeHealth Founders, Maryann speaks with Dr. Lara Zibners, co-founder of Calla Lily Clinical Care, about the inadequacies in current drug delivery methods for women's health. Lara shares her personal journey from being a physician to an entrepreneur, driven by her own experiences with infertility and the challenges of existing treatments.

With a broad background in clinical medicine and medical education in both the US and UK, Lara brings a unique understanding to Calla Lily of the scientific, systematic and business challenges facing women’s healthcare.

-----------

Current methods of vaginal drug delivery are profoundly inadequate for millions of women around the world. Calla Lily has developed a new leak-free vaginal drug delivery platform. It's simple to use (essential when patients have to administer medications themselves) and also helps to alleviate dosage anxiety and other stresses.

Innovators in Vaginal Drug Delivery | Calla Lily Clinical Care



Get full access to The Billion Dollar Blindspot at blog.billiondollarblindspot.com/subscribe

There's a vast, often overlooked frontier in business and innovation, and Blindspot Capital is mapping its terrain. This podcast digs into the ideas, trends, and tangible investment potential shaping the future of women's health, a sector that has historically been underfunded and underserved. Each episode moves beyond surface-level discussions to examine the systemic gaps and the consequential opportunities they create. You'll hear from founders, investors, researchers, and thinkers who are actively building and funding solutions in this space, sharing their on-the-ground experiences and hard-won insights. The conversations are grounded in the reality of entrepreneurship and market dynamics, exploring not just the "why" but the "how"-how new technologies are being applied, how businesses are scaling, and how capital can be deployed to generate both impact and returns. Tune in for a clear-eyed look at an area ripe for transformation, where understanding the blind spot isn't just about awareness, but about seeing a path forward for savvy builders and backers alike. This isn't a niche side conversation; it's a central dialogue about the next wave of growth in healthcare and technology, delivered through a podcast dedicated to substantive, forward-thinking analysis.
Author: Language: English Episodes: 18

Blindspot Capital
Podcast Episodes
What Real Science in Women’s Health Looks Like [not-audio_url] [/not-audio_url]

Duration: 25:15
Half the population experiences these conditions. Many are universal, recurring, and clinically significant. Yet in the eyes of too many investors, women’s health therapeutics remain “optional.”In this episode of Blindsp…
Blind Spot Capital is Here! [not-audio_url] [/not-audio_url]

Duration: 1:14
Blind Spot Capital Podcast TrailerWelcome to Blind Spot Capital, the podcast where health innovation meets investment insight. Every year, investors bet billions on the future of health but most still miss one of the big…
Episode #5: Transforming PostPartum Care with AI [not-audio_url] [/not-audio_url]

Duration: 52:08
In this conversation, Maryann and Astrid Gyllenkrok, CEO and Co-Founder of LEIA Health discuss the challenges of parenthood, particularly focusing on the postpartum experience and the need for better support systems for…
Episode #3 - The Story Behind OvulaRing [not-audio_url] [/not-audio_url]

Duration: 40:25
In this episode of Notes to Selfe, we dive into the fascinating world of women's health innovation with Sebastian Alexander, founder and CEO of VivoSensMedical. We explore the journey of OvulaRing, a groundbreaking techn…
Femme Health Founders Episode #1 [not-audio_url] [/not-audio_url]

Duration: 29:43
Hormones rule our lives—from puberty to menopause, they influence everything from our mood to our health. But why do some women experience severe side effects while others don’t?In this episode of the FemmeHealth Founder…